NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hematology



New findings in the area of hematology detailed



December 29th, 2005

Data on hematology are outlined in reports from Germany, the United States and Italy.

Study 1: Patient host factors prevent GB virus C infection in exposed hemophiliacs.

According to recent research published in the Journal of Clinical Virology, "until the mandatory introduction of viral inactivation techniques of blood plasma products in the early 1980s many recipients of these products were infected with various viral pathogens."

B. Kupfer and colleagues, University of Cologne conducted research "to determine the rate of transmission of GB virus C/hepatitis G virus (GBV-C/HGV), hepatitis C virus (HCV), and human...


Source: Blood Weekly (2005-12-29)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login